| AlMOF | Aluminum fumarate metal–organic framework |
| BET | Brunauer–Emmett–Teller |
| CD-MOFs | Cyclodextrin-based metal–organic frameworks |
| CMC | Carboxymethyl cellulose |
| DDSs | Drug-delivery systems |
| DOX | Doxorubicin |
| EPR | Enhanced permeability and retention |
| FA | Folic acid |
| FBF | Fenbufen |
| GA | L-glutamic acid |
| HIF-2α | Hypoxia-inducible factor 2α |
| IBU | Ibuprofen |
| IC50 | Half-maximal inhibitory concentration |
| ICP-MS | Inductively coupled plasma mass spectrometry |
| IR | Infrared radiation |
| JNK | c-Jun N-terminal kinase |
| κ-Cr | κ-carrageenan |
| MAPK | Mitogen-activated protein kinase |
| MOFs | Metal–organic frameworks |
| MMP | Matrix metalloproteinase |
| MSNs | Mesoporous silica nanoparticles |
| NCDs | Noncommunicable diseases |
| NF-κB | Nuclear factor kappa B |
| NMR | Nuclear magnetic resonance |
| PI3K/Akt | Phosphoinositide 3-kinase/protein kinase B |
| PLGA | Poly (lactic-co-glycolic acid) |
| PSM | Post-synthetic modification |
| PXRD | Powder X-ray diffraction |
| RGD | Arginine–glycine–aspartic acid |
| ROS | Reactive oxygen species |
| SA | Sodium alginate |
| SCXRD | Single-crystal X-ray diffraction |
| SEM | Scanning electron microscopy |
| siRNA | Small interfering RNA |
| SLNs | Solid lipid nanoparticles |
| STAT3 | Signal transducer and activator of transcription 3 |
| TEM | Transmission electron microscopy |
| TGA | Thermogravimetric analysis |
| TNBC | Triple-negative breast cancer |
| XPS | X-ray photoelectron spectroscopy |
| ZIF-8 | Zeolitic imidazolate framework-8 |